Submitted by Anonymous (not verified) on 17 May 2024 - 13:54
Human medicines European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde), irinotecan hydrochloride trihydrate, Date of authorisation: 14/10/2016, Revision: 12, Status: Authorised
Source: